About this trial

The purpose of this study is to evaluate the effectiveness of BEATLE with clinical samples of patients diagnosed with Developmental Language Disorder (DLD), Dyslexia, and Mixed Specific Developmental Disorder. A randomized controlled trial with a waitlist design will be employed. The objective is to assess potential changes in perceived self-efficacy, self-compassion, executive functioning, and attitudes toward learning as reported by the participants, their guardians (parents), and teachers. Additionally, this study aims to examine the correlation between the usage of the Digital Care Pathway (DCP) and its effectiveness.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • BEtter AT LEarning (BEATLE)- Digital Care Pathway

Treatment groups

312 Participants
are divided into 2 treatment groups

Locations

2
Pediatric Neurology, Helsinki University Hospital Helsinki Finland
Phoniatrics, Helsinki University Hospital Helsinki Finland

Sponsors and collaborators

Helsinki University Central Hospital

Lead sponsor